Your Cancer Treatment Record – evaluation surveys

Dear BOPA Members,
 
At the BOPA symposium in October the UK Chemotherapy Board and Cancer Research UK launched “Your Cancer Treatment Record”, a national patient-held treatment record for patients receiving systemic anti-cancer therapy. The records have been a huge success with over 40000 orders to date.
 
The team are now keen to receive feedback from HCPs and patients who have been using the record and have launched 2 surveys, one aimed at patients and the other at HCPs. The online surveys can be found below and paper copies may be requested via CRUK:
 
Patient survey: http://po.st/pacviews
HCP survey: http://po.st/hcpviews
 
BOPA would like to encourage members to share their views on this important and impactful project, with the aim of making the resource even better.
 
Many thanks,
Simon Purcell
(on behalf of the UKCB and CRUK)
 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article